Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
05/17/2001 | WO2001034629A1 21 human secreted proteins |
05/17/2001 | WO2001034628A1 35 human secreted proteins |
05/17/2001 | WO2001034627A1 28 human secreted proteins |
05/17/2001 | WO2001034623A1 29 human secreted proteins |
05/17/2001 | WO2001034614A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
05/17/2001 | WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists |
05/17/2001 | WO2001034608A1 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
05/17/2001 | WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
05/17/2001 | WO2001034605A1 SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS |
05/17/2001 | WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same |
05/17/2001 | WO2001034603A2 Bicyclic and tricyclic heteroaromatic compounds |
05/17/2001 | WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
05/17/2001 | WO2001034598A1 [(indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
05/17/2001 | WO2001034597A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
05/17/2001 | WO2001034586A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
05/17/2001 | WO2001034571A1 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
05/17/2001 | WO2001034562A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
05/17/2001 | WO2001034225A2 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
05/17/2001 | WO2001034201A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
05/17/2001 | WO2001034183A2 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
05/17/2001 | WO2001034178A2 Methods and compositions for treatment of traumatic brain injury |
05/17/2001 | WO2001034167A1 Isolation and expansion of human marrow stromal cells |
05/17/2001 | WO2001034166A1 Transplant/implant device and method for its production |
05/17/2001 | WO2001034165A1 Therapeutic compositions and methods of use thereof |
05/17/2001 | WO2001034161A1 A method of treating substance addiction |
05/17/2001 | WO2001034141A1 Il-8 receptor antagonists |
05/17/2001 | WO2001034138A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
05/17/2001 | WO2001034136A2 Use of adatanserin for the treatment of neurodegenerative conditions |
05/17/2001 | WO2001034125A2 Therapeutic use and formulation of (-)-tramadol |
05/17/2001 | WO2001034120A1 Apparatus and method for preparing microparticles using in-line solvent extraction |
05/17/2001 | WO2001034113A2 Apparatus and method for preparing microparticles |
05/17/2001 | WO2001034095A2 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
05/17/2001 | WO2001033942A1 Method for producing metabolites from plants cultivated in soil-less medium |
05/17/2001 | WO2001018043A3 Neurogenic compositions and methods |
05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
05/17/2001 | WO2001009116A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
05/17/2001 | WO2001005390A3 Method for treating chronic pain using mek inhibitors |
05/17/2001 | WO2001004157A3 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
05/17/2001 | WO2001003648A3 Oregano-based therapeutic composition |
05/17/2001 | WO2001001973A8 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
05/17/2001 | WO2000049137B1 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
05/17/2001 | WO2000041484A3 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
05/17/2001 | DE19954707A1 Imidazolverbindungen als Phosphodiesterase VII-Hemmer Imidazole compounds as phosphodiesterase VII inhibitor |
05/17/2001 | DE19953339A1 Secretinfragmente Secretinfragmente |
05/17/2001 | CA2854796A1 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
05/17/2001 | CA2428827A1 Human vanilloid receptor gene |
05/17/2001 | CA2391278A1 Therapeutic compositions and methods of use thereof |
05/17/2001 | CA2390880A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
05/17/2001 | CA2390834A1 Transplant/implant device and method for its production |
05/17/2001 | CA2390797A1 Methods for the treatment and prevention of neurodegenerative conditions |
05/17/2001 | CA2390655A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
05/17/2001 | CA2390531A1 ¬(indol-3-yl)-cycloalkyl|-3-substituted azetidines for the treatment of central nervous system disorders |
05/17/2001 | CA2390530A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
05/17/2001 | CA2390524A1 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
05/17/2001 | CA2390510A1 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
05/17/2001 | CA2390496A1 Polycycloalkylpurines as adenosine receptor antagonists |
05/17/2001 | CA2390438A1 19 human secreted proteins |
05/17/2001 | CA2390421A1 24 human secreted proteins |
05/17/2001 | CA2390376A1 .beta.-aminoacid compounds useful for inhibiting .beta.-amyloid peptide release and/or its synthesis |
05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
05/17/2001 | CA2390161A1 Methods for identifying and using amyloid-inhibitory compounds |
05/17/2001 | CA2390101A1 A method of treating substance addiction |
05/17/2001 | CA2389724A1 28 human secreted proteins |
05/17/2001 | CA2389722A1 15 human secreted proteins |
05/17/2001 | CA2389488A1 Isolation and expansion of human marrow stromal cells |
05/17/2001 | CA2389392A1 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
05/17/2001 | CA2389326A1 35 human secreted proteins |
05/17/2001 | CA2389193A1 Hydromorphone compositions and methods of their synthesis |
05/17/2001 | CA2389041A1 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or .beta.-sheet rich pathological precursor thereof |
05/17/2001 | CA2388912A1 6 human secreted proteins |
05/17/2001 | CA2388750A1 .beta.-aminoacid compounds useful for inhibiting .beta.-amyloid peptide release and/or its synthesis |
05/17/2001 | CA2388729A1 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
05/17/2001 | CA2388644A1 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
05/17/2001 | CA2388593A1 Bicyclic and tricyclic heteroaromatic compounds |
05/17/2001 | CA2388343A1 Methods for inhibiting neurofibromatosis type 1 (nf1) |
05/17/2001 | CA2388019A1 24 human secreted proteins |
05/17/2001 | CA2388008A1 29 human secreted proteins |
05/17/2001 | CA2387964A1 22 human secreted proteins |
05/17/2001 | CA2387959A1 21 human secreted proteins |
05/17/2001 | CA2387624A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
05/17/2001 | CA2361139A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods |
05/17/2001 | CA2359955A1 Human vanilloid receptor gene |
05/16/2001 | EP1099702A1 Substituted morpholine derivatives and their use as therapeutic agents |
05/16/2001 | EP1099692A1 N,n-substituted cyclic amine derivatives |
05/16/2001 | EP1099446A2 Combination treatment for depression and anxiety containing a CNS-penetrant NK-1 receptor antagonist and an antidepressant or anxiolytic agent |
05/16/2001 | EP1099445A2 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
05/16/2001 | EP1099443A1 Transplant/implant device and method for its production |
05/16/2001 | EP1098985A1 Genes of the dead box protein family, their expression products and use |
05/16/2001 | EP1098978A1 Gbs toxin receptor |
05/16/2001 | EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
05/16/2001 | EP1098906A1 Peptide analogues of pacap |
05/16/2001 | EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
05/16/2001 | EP1098896A1 5-bicycloindole compounds |
05/16/2001 | EP1098894A1 Fkbp inhibitors |
05/16/2001 | EP1098892A1 Biphenyl derivatives |
05/16/2001 | EP1098884A1 Il-8 receptor antagonists |
05/16/2001 | EP1098871A1 $g(a)-AMINO ACID PHENYL ESTER DERIVATIVES |